Why full FDA approval of the Pfizer vaccine wasn't the 'silver bullet' for vaccination rates
Even though health officials had hoped the opposite to be true, a federal government analysis suggests full FDA approval of Pfizer's COVID-19 vaccine had only a "modest and relatively short-lived" effect on vaccination rates, CNN reports. In other words, while there was a resulting uptick, full licensure was not the "silver bullet" to completely eliminate vaccine hesitancy.
"There weren't suddenly lines around the block," said Becca Siegel, a senior adviser to the U.S. Department of Health and Human Services. That's because for "truly undecided people, this is a complex decision. It's not one thing," Siegel explained.
Notably, fear (whether that's of getting sick or of missing out), social pressure from friends and families, employer mandates, and concerns regarding the Delta variant were more likely to bolster vaccination rates in hesitant individuals than full FDA approval, CNN notes, per polling from the Kaiser Family Foundation.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Still, licensure could play an otherwise long-term role in convincing Americans to roll up their sleeves. "We won't see the impact of approval on day one, hour one, but could see it over a long period of time," said Siegel. "This is a slow, steady march."
And as the U.S. inches toward the finish line, "I think we've come to recognize that mandates are what we've come to in order to really generate increases in vaccination," added John Browstein of Boston Children's Hospital. "Mandates are super important to cover the last mile for those who are on the fence." Read more at CNN.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
When is an offensive social media post a crime?
The Explainer UK legal system walks a 'difficult tightrope' between defending free speech and prosecuting hate speech
By The Week UK Published
-
Women are getting their own baseball league again
In the Spotlight The league is on track to debut in 2026
By Justin Klawans, The Week US Published
-
Giant TVs are becoming the next big retail commodity
Under the Radar Some manufacturers are introducing TVs over 8 feet long
By Justin Klawans, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published